Cancer Research and Anticancer Therapies September 17-18, 2018
July 17 - July 18
About the Conference
Conference Series Ltd. invites all potential participants across the world to join the 28th International Conference on Cancer Research and Anticancer Therapies which is going to be held during September 17-18, 2018 San Diego, USA.
Cancer Congress 2018 is a trending event which brings together efficient international academic scientists, young researchers and students making the congress a perfect platform to share experiences, gain and evaluate emerging technologies in Cancer Treatment and Radiology across the globe. Initiation of cross-border co-operations between scientists and institutions will also be facilitated. The main theme of the Conference is “Furtherance and Innovations in Cancer Care”.
Cancers are a large family of diseases which involve abnormal cell growth with the potential to invade or spread to other parts of the body. A neoplasm or tumor is a group of cells which have undergone unregulated and uncontrolled growth and will often form a mass or lump, but may be distributed diffusely.
Cancer research extensively ranges from epidemiology, molecular level research to the performance of clinical trials to evaluate and compare applications of the various cancer treatments. Many treatment options for cancer exist. The primary ones include surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy, palliative care and immunotherapy and combined treatment modalities such as chemo-radiotherapy.
Conference Series Ltd. organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe and Asia with support from 1000 more scientific societies and published 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as Editorial Board Members.
Radiology and Oncology Students, Cancer Researchers, Scientists, Radiology and Oncology Researchers, Radiology and Oncology Faculty, Medical Colleges, Scientists, Doctors, Professors, Oncology Lecturers, Researchers, Pharmaceutical Industries, Healthcare Industries, Directors of Association and Societies, Cancer and Radiology Training Institutes, Staff development educators.